EFFECT OF A PRACTICE-WIDE ANTI-TNF THERAPEUTIC DRUG MONITORING PROGRAM ON OUTCOMES IN PEDIATRIC PATIENTS WITH INFLAMMATORY BOWEL DISEASE

被引：0
|
作者：
Lyles, John L.
Mulgund, Aditi A.
Bauman, Laura E.
Su, Weizhe
Fei, Lin
Chona, Deepika
Sharma, Puneet
Etter, Renee
Hellmann, Jennifer
Denson, Lee A.
Minar, Phillip P.
Dykes, Dana M.
Rosen, Michael J.
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
303
引用
收藏
页码：S60 / S60
页数：1
相关论文
共 50 条
  • [31] Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience
    Chaya Shwaartz
    Adam C. Fields
    Maximiliano Sobrero
    Brian D. Cohen
    Celia M. Divino
    Journal of Gastrointestinal Surgery, 2016, 20 : 1636 - 1642
  • [32] Effect of Anti-TNF Agents on Postoperative Outcomes in Inflammatory Bowel Disease Patients: a Single Institution Experience
    Shwaartz, Chaya
    Fields, Adam C.
    Sobrero, Maximiliano
    Cohen, Brian D.
    Divino, Celia M.
    JOURNAL OF GASTROINTESTINAL SURGERY, 2016, 20 (09) : 1636 - 1642
  • [33] Advantages of a fully automated chemiluminescent method for therapeutic drug monitoring (TDM) of anti-TNFα in patients with Inflammatory Bowel Diseases
    Cifu, A.
    Marino, M.
    Sablich, R.
    Carletti, M.
    Blasone, N.
    Milloch, S.
    Curcio, F.
    Fabris, M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I289 - I289
  • [34] Effect of Anti-TNFα Therapy on Prevalence of Depression in Patients With Inflammatory Bowel Disease
    Loomes, Dustin E.
    Dittrich, Alexandra E.
    Madsen, Karen
    Dieleman, Levinus A.
    Halloran, Brendan P.
    Fedorak, Richard N.
    Kroeker, Karen I.
    GASTROENTEROLOGY, 2014, 146 (05) : S779 - S779
  • [35] OUTCOMES FOLLOWING THE INTRODUCTION OF WEEK 12 ANTI-TNF DRUG AND ANTIBODY TESTING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Boal, A.
    Squires, S. I.
    Naismith, G. D.
    GUT, 2017, 66 : A252 - A253
  • [36] OUTCOMES FOLLOWING THE INTRODUCTION OF ANTI-TNF DRUG AND ANTIBODY TESTING TO A BIOLOGICS CLINIC FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Boal, A.
    Squires, S. I.
    Naismith, G. D.
    GUT, 2017, 66 : A257 - A257
  • [37] Therapeutic Drug Monitoring in Practice for Inflammatory Bowel Disease
    Megna B.W.
    Vaughn B.P.
    Current Gastroenterology Reports, 2022, 24 (12) : 191 - 200
  • [38] IMPACT OF THERAPEUTIC DRUG MONITORING ON OUTCOMES FOR PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Hussenbux, Arif
    Chopra, Tanya
    Stearns, Rebecca
    Ravindran, Rahul
    Patodi, Nishant
    De Silva, Aminda
    GUT, 2021, 70 : A100 - A100
  • [39] ANTI-TNF INDUCED LYMPHOCYTOSIS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Soufleris, Konstantinos
    Kafalis, Nikolaos
    Fasoulas, Konstantinos
    Pilpilidis, Ioannis
    Lazaraki, Georgia
    Markala, Dimitra
    Tzilves, Dimitris
    GASTROENTEROLOGY, 2019, 156 (06) : S635 - S635
  • [40] Optimization of anti-TNF therapy in patients with Inflammatory Bowel Disease
    Strik, A. S.
    Bots, S. J. A.
    D'Haens, G.
    Lowenberg, M.
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2016, 9 (03) : 429 - 439
12345